Association of the 677C→T polymorphism in the MTHFR gene with colorectal cancer in Mexican patients

Cancer Genomics and Proteomics

Volumn 6, Issue 3, 2009, Pages 183-188

  Gallegos Arreola, Martha Patricia ^a,b   Garcia Ortiz J E ^a   Figuera, L E ^a   Puebla Perez A M ^a   Morgan Villela, G ^a   Zuniga Gonzalez G M ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

Author keywords

Colorectal cancer; Mexican population; MTHFR; Polymorphism

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL EVALUATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; COLORECTAL TUMOR; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MEXICO; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 67649494692     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Kinzker KW and Vogelstein B: Colorectal Cancer. In: The Genetic Basis of Human Cancer. Kinzker KW and Vogelstein B (eds.). New York, McGraw-Hill, pp. 565-587, 1998.
2. Mareel M and Leroy A: Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83: 337-376, 2003. (Pubitemid 36382891)
3. Elmore CL and Matthews RG: The many flavors of hyperhomocyst(e)inemia: insights from transgenic and inhibitor-based mouse models of disrupted one-carbon metabolism. Antioxid Redox Signal 9: 1911-1921, 2007. (Pubitemid 47622352)
4. Mangiagalli A, Samuele A, Armentero MT, Bazzini E, Nappi G and Blandini F: Effects of homocysteine on apoptosis-related proteins and anti-oxidant systems in isolated human lymphocytes. Eur J Biochem 271: 1671-1676, 2004. (Pubitemid 38586299)
5. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB and Ames BN: Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94: 3290-3295, 1997. (Pubitemid 27157304)
6. Pogribny IP, Muskhelishvili L, Miller BJ and James SJ: Presence and consequence of uracil in preneoplastic DNA from folate/methyl-deficient rats. Carcinogenesis 18: 2071-2076, 1997. (Pubitemid 28134731)
7. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y and White R: Allelotype of colorectal carcinomas. Science 244: 207-211, 1989. (Pubitemid 19110299)
8. Bailey LB and Gregory JF, III: Folate metabolism and requirements. J Nutr 129: 779-782, 1999.
9. Bjorke Monsen AL and Ueland PM: Homocysteine and methylmalonic acid in diagnosis and risk assessment from infancy to adolescence. Am J Clin Nutr 78: 7-21, 2003. (Pubitemid 39655243)
10. Forges T, Monnier-Barbarino P, Alberto JM, Gueant-Rodriguez RM, Daval JL and Gueant JL: Impact of folate and homocysteine metabolism on human reproductive health. Hum Reprod Update 13: 225-238, 2007. (Pubitemid 47064259)
11. Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, Willett WC and Hunter DJ: A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 56: 4862-4864, 1996. (Pubitemid 26374419)
12. Peyrin-Biroulet L, Barraud H, Ancel D, Petit-Laurent F, Bigard MA, Gueant JL and Bronowicki JP: Folate metabolism and colorectal carcinogenesis. Gastroenterol Clin Biol 28: 582-592, 2004. (Pubitemid 38917491)
13. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA and Morgan G: Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96: 12810-12815, 1999. (Pubitemid 29513584)
14. Ueland PM, Hustad S, Schneede J, Refsum H and Vollset SE: Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 22: 195-201, 2001. (Pubitemid 32244306)
15. Osian G, Procopciuc L and Vlad L: MTHFR polymorphisms as prognostic factors in sporadic colorectal cancer. J Gastrointestin Liver Dis 16: 251-256, 2007. (Pubitemid 47518386)
16. Ryan BM, Molloy AM, McManus R, Arfin Q, Kelleher D, Scott JM and Weir DG: The methylenetetrahydrofolate reductase (MTHFR) gene in colorectal cancer: role in tumor development and significance of allelic loss in tumor progression. Int J Gastrointest Cancer 30: 105-111, 2001. (Pubitemid 36306726)
17. Ulrich CM, Bigler J, Bostick R, Fosdick L and Potter JD: Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res 62: 3361-3364, 2002. (Pubitemid 34651378)
18. Cao HX, Gao CM, Takezaki T, Wu JZ, Ding JH, Liu YT, Li SP, Su P, Cao J, Hamajima M and Tajima K: Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer. Asian Pac J Cancer Prev 9: 203-208, 2008.
19. Iacopetta B, Heyworth J, Grischik J, Grieu F, Clayforth C and Fritschi L: The MTHFR C677T and Delta DNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectal cancer. Int J Cancer [Epub ahead of print]: Feb 3, 2009.
20. Derwinger K, Wettergren Y, Odin E, Carlsson G and Gustavsson B: A study of the MTHFR gene polymorphism C677T in colorectal cancer. Clin Colorectal Cancer 8: 43-48, 2009.
21. Isotalo PA and Donnelly JG: Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis. Mol Diagn 5: 59-66, 2000. (Pubitemid 30165066)
22. Kluijtmans LA, Kastelein JJ, Lindemans J, Boers GH, Heil SG, Bruschke AV, Jukema JW, van den Heuvel LP, Trijbels FJ, Boerma GJ, Verheugt FW, Willems F and Blom HJ: Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation 96: 2573-2577, 1997. (Pubitemid 27451348)
23. Davalos IP, Olivares N, Castillo MT, Cantu JM, Ibarra B, Sandoval L, Moran MC, Gallegos MP, Chakraborty R and Rivas F: The C677T polymorphism of the methylenetetrahydrofolate reductase gene in Mexican mestizo neural-tube defect parents, control mestizo and native populations. Ann Genet 43: 89-92, 2000. (Pubitemid 30740071)
24. Esfahani ST, Cogger EA and Caudill MA: Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups. J Am Diet Assoc 103: 200-207, 2003. (Pubitemid 38375921)
25. Gallegos-Arreola MP, Figuera LE, Delgado JL, Puebla-Perez AM and Zuniga-Gonzalez GM: The MTHFR polymorphism C677T in adult patients with acute lymphoblastic leukemia is associated with an increased prevalence of cytogenetic abnormalities. Blood Cells Mol Dis 40: 244-245, 2008. (Pubitemid 351221385)
26. Gueant-Rodriguez RM, Gueant JL, Debard R, Thirion S, Hong LX, Bronowicki JP, Namour F, Chabi NW, Sanni A, Anello G, Bosco P, Romano C, Amouzou E, Arrieta HR, Sanchez BE, Romano A, Herbeth B, Guilland JC and Mutchinick OM: Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. Am J Clin Nutr 83: 701-707, 2006. (Pubitemid 44699219)
27. Miller SA, Dykes DD and Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988.
28. Sanguinetti CJ, Dias Neto E and Simpson AJ: Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 17: 914-921, 1994. (Pubitemid 24346012)
29. Alonso A, Moreno S, Valiente A, Artigas M, Perez-Juana A and Ramos Arroyo MA: Genetic mechanisms in the hereditary predisposition to colorectal cancer. An Sist Sanit Navar 29: 59-76, 2006. (Pubitemid 43754075)
30. Gross CP, McAvay GJ, Krumholz HM, Paltiel AD, Bhasin D and Tinetti ME: The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med 145: 646-653, 2006. (Pubitemid 46768839)
31. Duran RO, Gonzalez OA, Cisneros LFJ and Hermosillo SJM: Experience in the management of colo-rectal cancer in the Centro Medico Nacional de Occidente (National Medical Center of the West). Cir Gen 22: 153-158 2000.
32. Hendon SE and DiPalma JA: U.S. practices for colon cancer screening. Keio J Med 54: 179-183, 2005. (Pubitemid 43200932)
33. Beral V, Banks E and Reeves G: Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 360: 942-944, 2002. (Pubitemid 35283842)
34. Brenner H, Hoffmeister M, Arndt V and Haug U: Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer 96: 828-831, 2007. (Pubitemid 46376632)
35. McCashland TM, Brand R, Lyden E and de Garmo P: Gender differences in colorectal polyps and tumors. Am J Gastroenterol 96: 882-886, 2001. (Pubitemid 32240749)
36. Chen HS and Sheen-Chen SM: Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends. Surgery 127: 370-376, 2000. (Pubitemid 30225987)
37. Promrat K, Aziz K and Wu GY: Screening for Colorectal Cancer. In: Cancer Screening: A Practical Guide for Physicians. Aziz K and Wu GY (eds.). Totowa, NJ, Humana Press, pp. 87-109, 2001.
38. Jacobson JS, Neugut AI, Murray T, Garbowski GC, Forde KA, Treat MR, Waye JD, Santos J and Ahsan H: Cigarette smoking and other behavioral risk factors for recurrence of colorectal adenomatous polyps (New York City, NY, USA). Cancer Causes Control 5: 215-220, 1994. (Pubitemid 24186009)
39. Slattery ML, Anderson K, Curtin K, Ma KN, Schaffer D and Samowitz W: Dietary intake and microsatellite instability in colon tumors. Int J Cancer 93: 601-607, 2001. (Pubitemid 32701421)
40. Slattery ML, Curtin K, Anderson K, Ma KN, Ballard L, Edwards S, Schaffer D, Potter J, Leppert M and Samowitz WS: Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 92: 1831-1836, 2000. (Pubitemid 30945198)
41. Solera Albero J, Tarraga Lopez PJ, Carbayo Herencia JA, Lopez Cara MA, Celada Rodriguez A, Cerdan Oliver M and Ocana Lopez JM: [Influence of diet and lifestyle in colorectal cancer]. Rev Esp Enferm Dig 99: 190-200, 2007.
42. Zisman AL, Nickolov A, Brand RE, Gorchow A and Roy HK: Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for screening. Arch Intern Med 166: 629-634, 2006.
43. Terry MB and Neugut AI: Cigarette smoking and the colorectal adenoma-carcinoma sequence: a hypothesis to explain the paradox. Am J Epidemiol 147: 903-910, 1998. (Pubitemid 128721158)
44. Perera FP: Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst 88: 496-509, 1996. (Pubitemid 26118720)
45. Kim YI: Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: a paradigm of gene-nutrient interactions in carcinogenesis. Nutr Rev 58: 205-209, 2000. (Pubitemid 30642796)
46. Shannon B, Gnanasampanthan S, Beilby J and Iacopetta B: A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability. Gut 50: 520-524, 2002. (Pubitemid 34638872)
47. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH and Rozen R: Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57: 1098-1102, 1997. (Pubitemid 27138608)